Economy, business, innovation

Markets

ADMA Biologics, Inc. (ADMA) Jumps 7.6% to $10.44

ADMA Price $10.44 Change +7.6% Volume 1.2M Shares of ADMA Biologics surge 7.6% on Monday. The biotechnology company’s stock climbed to $10.44 on April 13, 2026, as investors reacted to positive momentum across the healthcare sector, with the stock trading among notable movers including Leggett & Platt, Allogene Therapeutics, and Revolution Medicines. The catalyst remains […]

ADMA Biologics, Inc. (ADMA) Jumps 7.6% to $10.44 Read More »

Celanese Corporation Shares Jump 5.2%

CE Price $66.41 Change +5.2% Volume 491,272 Celanese Corporation (NYSE: CE) surged 5.2% Monday to $66.41 after recent dual analyst upgrades that lifted price targets by an average of 8.6%. The chemical manufacturer’s shares rallied on 491,272 shares of volume as Wall Street analysts turned more bullish on the stock’s near-term prospects. The synchronized analyst

Celanese Corporation Shares Jump 5.2% Read More »

Akamai Technologies, Inc. Jumps 6.6% in Broad Rally

AKAM Price $97.37 Change +6.6% Volume 1.8M Akamai Technologies Inc. (NASDAQ: AKAM) surged 6.6% Monday to trade at $97.37, riding a broad rally across software infrastructure peers. The content delivery and cloud services provider jumped alongside other tech players CRWV, SNOW, and DOCN in a coordinated move that lifted valuations across the group. The rally

Akamai Technologies, Inc. Jumps 6.6% in Broad Rally Read More »

FGI Industries: Margin Expansion and Strategic BPC Growth Amidst Tariff Headwinds in Q4 2025

Business Overview FGI Industries Ltd. is a leading global business-to-business supplier of kitchen and bath products. Founded in 1988 in conjunction with its parent company, Foremost Groups Ltd., FGI has established an industry-wide reputation for product innovation, quality, and customer service. The Company completed its initial public offering (IPO) in January 2022. FGI’s product portfolio

FGI Industries: Margin Expansion and Strategic BPC Growth Amidst Tariff Headwinds in Q4 2025 Read More »

Abbott Laboratories set to report Q1 FY26 earnings. Here’s what to expect

Abbott Laboratories (NYSE: ABT) enters fiscal 2026 with a growing profile, increasingly driven by sustained momentum in medical devices—particularly diabetes care and electrophysiology. Meanwhile, headwinds in diagnostics and nutrition are easing but still weigh on overall performance. The company’s guidance for high single-digit organic sales growth underscores confidence in its diversified portfolio despite broader healthcare

Abbott Laboratories set to report Q1 FY26 earnings. Here’s what to expect Read More »

Byrna Technologies: Financial Performance, Retail Expansion, and Strategic Realignment

Business Overview Byrna Technologies Inc. is a personal defense technology company that specializes in the development, manufacture, and sale of innovative less-lethal personal security solutions. The Company’s core product lineup includes the Byrna CL, Byrna LE, and Byrna SD personal security devices. These devices are state-of-the-art, handheld, CO2-powered launchers designed to provide a less-lethal alternative

Byrna Technologies: Financial Performance, Retail Expansion, and Strategic Realignment Read More »

Lotus Technology Inc: Margin Expansion and Strategic Powertrain Pivots Amidst Transitional Headwinds

Company Overview and Business Profile Lotus Technology Inc. (Nasdaq: LOT) operates as a prominent global intelligent and luxury mobility provider. The Company maintains a multinational footprint with established operations across the United Kingdom, the European Union, and China. Lotus Technology is primarily dedicated to the delivery of luxury lifestyle electric vehicles. A core component of

Lotus Technology Inc: Margin Expansion and Strategic Powertrain Pivots Amidst Transitional Headwinds Read More »

Goldman Sachs (GS) Q1 FY26 earnings rise on higher revenues, beat estimates

Banking giant Goldman Sachs Group, Inc. (NYSE: GS) reported stronger-than-expected earnings for the first quarter of fiscal 2026. Total revenues climbed 14% during the three months. First-quarter earnings, on a per-share basis, rose sharply to $17.55 from $14.12 in the corresponding quarter of fiscal 2025. Net income was $5.63 billion in the first quarter, compared

Goldman Sachs (GS) Q1 FY26 earnings rise on higher revenues, beat estimates Read More »

Scroll to Top